Researchers Plan to Investigate Role of Autoantibodies in Cancer Risk, Immune Response

1 hour ago
Chris@BMW

For a long time, scientists have wondered why many individuals that have several risk factors linked to cancer development never develop the disease while some…

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Combining Three Emerging Frontiers in Cancer Drug Development

1 day ago

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. As precision oncology becomes increasingly dependent on…

Regentis Biomaterials Ltd. (NYSE American: RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3 Billion Cartilage Repair Market

4 days ago

Regentis is targeting an estimated $3 billion U.S. cartilage repair market opportunity, supported by approximately 470,000 annual knee cartilage repair…

Health Insurance Keeps 25% of US Employees Locked in Their Jobs

4 days ago

According to the findings of a recent poll conducted by Gallup and West Health, almost a quarter of employees within the U.S.,…

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Precision Oncology as Biomarker-Driven Cancer Gains Momentum

5 days ago

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. ONC010 is being developed for biomarker-selected cancers,…

Recent Communicable Disease Outbreaks Highlight Gaps in Public Health Systems

5 days ago

The U.S. has recently had outbreaks of a number of infectious diseases, such as measles, mpox and HIV. These outbreaks have exposed critical gaps that exist…

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany

6 days ago

The company has received Scientific Advice from Germany’s Paul-Ehrlich-Institute (“PEI”) supporting the proposed development strategy for its lead BiTAC(R)-TCE program.…

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Developing Two-Pronged Attack on Brain Disorders Affecting Millions

7 days ago

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma’s MS focus is Lucid-MS, a patented…

Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer

1 week ago

For a long time, many people have claimed that using a mobile phone can cause brain cancer. These fears were…

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Hits Key Study Milestone as Early MS Imaging Data Shows Promising Signal

1 week ago

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Multiple sclerosis is one of the most…